Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Apr 06, 2022

Dr. Reddy's, Mindtree, ICICI Securities And More - Top Stock Picks For April: KRChoksey

Dr. Reddy's, Mindtree, ICICI Securities And More - Top Stock Picks For April: KRChoksey

Dr. Reddy's, Mindtree, ICICI Securities And More - Top Stock Picks For April: KRChoksey
A dealer handles playing cards on a table at a casino. (Photographer: Xaume Olleros/Bloomberg)

BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

KRChoksey Research Report

Investment period: six months. Research idea: Fundamental

Dr Reddy's Laboratories Ltd. - The company has recently got an U.S. Food and Drug Administration approval to market generic of blockbuster Revlimid (Lenalidomide) for 2.5 mg and 20.0 mg strengths and tentative approvals for 5 mg, 10 mg, 15 mg and 25 mg strengths in the U.S.

Dr. Reddy's is likely to sell limited quantity of the approved drugs between FY23-FY26 in the U.S. The company has launched Lenalidomide in Canada in Q2FY22.

Mindtree Ltd. - Mindtree continues to stay focused on the 4x4x4 strategy and believes that sharp focus on the service lines leads to improvement in capabilities and success in digital business and has successfully de-risked itself by lowering its exposure to its largest client (Microsoft), down to ~25% of revenue from 30% at the peak.

ICICI Securities Ltd. - ICICI Securities is expected to increase its market share across its diverse segments on account of technology adoption and customer oriented product services. We estimate revenue / profit after tax both to grow at 24% during FY21-23E, respectively.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Listen to the latest songs, only on JioSaavn.com